
About Gel4Med
Gel4Med is a Healthcare company based in Boston (United States) founded in 2015. Gel4Med is focused on developing bioinspired medical solutions. It operates on a HealthTech and Direct-to-Consumer (D2C) model. The company has 9 employees. Gel4Med offers products and services including G4Derm™ Plus, G4Derm™, and Smart Materials Platform™. Its focus areas include Medical Devices and Wound Care. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Gel4Med is engaged in the development of advanced medical solutions through bioinspiration and materials engineering. The company is based on its proprietary Smart Materials Platform technology, which is utilized to address unmet clinical needs in wound care and surgical reconstruction. Products such as G4Derm and G4Derm Plus have been cleared by the FDA for market use. Collaborations with institutions like the University of Miami for spinal cord injury treatments are also pursued. The company operates within the healthcare sector, focusing on innovative biomaterials to improve patient outcomes.
- Headquarters Boston, United States
- Employees 9
- SectorsHealthcare
- Email••••••••
- Website gelformed.com
- Social LinkedIn X
- Legal Name Gel4med
- Latest Funding Round$2.65M (USD), Grant
Sep 2023
- InvestorsHHS
& 3 more
- Employee Count9
Products & Services of Gel4Med
Gel4Med offers a comprehensive portfolio of products and services, including G4Derm™ Plus, G4Derm™, and Smart Materials Platform™.
A flowable biomimetic matrix for managing complex wounds.
A biosynthetic matrix for wound care and reconstruction.
A bioengineering platform for developing therapeutics and devices.
Funding Insights of Gel4Med
- Total Rounds 11
- Last Round Grant — $2.65M
- First Round $9,000
(Apr 2015)
- Investors Count 4
Latest 10 of 11 funding rounds of Gel4Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $2.65M | Grant | – | – | |
| Aug 2020 | $300,000 | Grant | – | – | |
| Jul 2020 | $409,704 | Grant | – | – | |
| Apr 2019 | $4.28M | Grant | – | – | |
| Feb 2019 | $225,000 | Grant | – | – | |
| Sep 2017 | $292,475 | Grant | – | – | |
| Sep 2017 | $298,530 | Grant | – | – | |
| Apr 2017 | Grant | – | – | ||
| Apr 2017 | $223,866 | Grant | – | – | |
| May 2016 | $223,369 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Gel4Med
Gel4Med has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, UMass Lowell and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Early-stage science-driven companies are supported through venture capital investments. | breakoutlabs.org | |||
Undergraduate and graduate education programs are provided across disciplines. | 1894 | uml.edu | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Gel4Med
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gel4Med
1 people are tracked at Gel4Med (1 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Manav Mehta | Chief Executive Officer | Leadership |
Complete people profiles for Gel4Med
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Gel4Med
3 dated milestones of Gel4Med across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Gel4Med is founded.
- Funding First funding round of $9K.
- Funding Latest funding round, Grant, of $2.6M.
Competitors of Gel4Med
Gel4Med has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Gel4Med
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Gel4Med (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gel4med
Complete news archive for Gel4Med
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gel4Med
Gel4Med was founded in 2015.
Gel4Med is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Gel4Med has 9 employees.
Gel4Med is engaged in the development of advanced medical solutions through bioinspiration and materials engineering. The company is based on its proprietary Smart Materials Platform technology, which is utilized to address unmet clinical needs in wound care and surgical reconstruction. Products such as G4Derm and G4Derm Plus have been cleared by the FDA for market use. Collaborations with institutions like the University of Miami for spinal cord injury treatments are also pursued. The company operates within the healthcare sector, focusing on innovative biomaterials to improve patient outcomes.
Gel4Med's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Gel4Med offers G4Derm™ Plus, G4Derm™, and Smart Materials Platform™.
Gel4Med has 4 investors. Key investors include HHS, UMass Lowell, America’s Seed Fund, and Breakout Ventures.
Gel4Med operates through Gel4med.
